Kodiak Sciences Inc.
NASDAQ Global MarketTotal Valuation
Kodiak Sciences Inc. carries a market capitalization of 1.76B, placing it among publicly traded companies globally. Its enterprise value stands at 2.00B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.76B |
| Enterprise Value | 2.00B |
Share Statistics
Kodiak Sciences Inc. currently has 62.16M shares outstanding.
| Shares Outstanding | 62.16M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -1.31 |
| P/TBV Ratio | 18.87 |
| P/FCF Ratio | -14.51 |
| P/OCF Ratio | -14.39 |
Financial Position
Kodiak Sciences Inc. maintains a current ratio of 3.54, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.54 |
| Quick Ratio | 3.42 |
| Debt / Equity | 49.95 |
| Debt / EBITDA | -0.27 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -76.39 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Kodiak Sciences Inc.'s stock has gained approximately 743.0203% over the past 52 weeks. The 50-day moving average sits at 39.46, while the 200-day moving average is 24.96.
| Beta (5Y) | N/A |
| 52-Week Price Change | 743.0203% |
| 50-Day Moving Average | 39.46 |
| 200-Day Moving Average | 24.96 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -209.16M, while operating income came in at -235.09M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -235.09M |
| Pretax Income | -230.66M |
| Net Income | -230.66M |
| EBITDA | -209.16M |
| EBIT | -235.09M |
| Earnings Per Share (EPS) | -4.16 |
Balance Sheet
Kodiak Sciences Inc. holds 169.53M in cash and equivalents against 55.99M in total debt, resulting in a net debt position of -169.53M. Total book value stands at -1.62B, with working capital of 125.69M providing operational flexibility.
| Cash & Cash Equivalents | 169.53M |
| Total Debt | 55.99M |
| Net Debt | -169.53M |
| Equity (Book Value) | -1.62B |
| Book Value Per Share | -29.14 |
| Working Capital | 125.69M |
Cash Flow
Kodiak Sciences Inc. produced -146.94M in operating cash flow over the past twelve months. After subtracting -1.18M in capital expenditures, free cash flow totaled -148.12M - equivalent to -2.67 per share.
| Operating Cash Flow | -146.94M |
| Capital Expenditures | -1.18M |
| Free Cash Flow | -148.12M |
| FCF Per Share | -2.67 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -8.45 |
| FCF Yield | -6.89 |
Stock Splits
Kodiak Sciences Inc.'s most recent stock split took place on February 23, 2022 with a 1:5 split ratio.
| Last Split Date | 2/23/2022 |
| Split Ratio | 1:5 |
Scores
Kodiak Sciences Inc. posts an Altman Z-Score of -2.90, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -2.90 |